BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Clofibrate
,
rs2230926
,
SIRT1
,
Inflammatory disorder
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Iron Dextran
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
There were no matches for Iron Dextran
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
There were no matches for Iron Dextran
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Dysregulation of Macrophage Activation Profiles by Engineered Nanoparticles
Lungs exposed to superparamagnetic iron oxide nanoparticle aerosol - Timecourse
Effects of labelling fetal MSC with MRI Particles- MGIO and Ferucarbotran
Explore Curated Studies Results
Literature
Most Relevant Literature
Minimally invasive transdermal delivery of iron-dextran.
Pharmacokinetics of combined administration of iron dextran with meloxicam or flunixin meglumine in …
Hepatic Response to the Interaction Between Thymoquinone and Iron-Dextran: an In Vitro and In Vivo S…
Effects of Volatile Anaesthetics and Iron Dextran on Chronic Inflammation and Antioxidant Defense Sy…
Iron deficiency in sepsis patients managed with divided doses of iron dextran: a prospective cohort …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Short-term Intravenous Iron Dextran for IDA
Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy U…
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency …
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficien…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ